Martin Dahl, PhD, of AnaptysBio discusses the findings and limitations of a study analyzing use of ANB032 in patients with atopic dermatitis (AD). Martina Porter, MD, FAAD, vice chair of research ...
Some results have been hidden because they may be inaccessible to you